Optimize Financial’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$466K Buy
+3,306
New +$471K 0.09% 182

Other funds holding PTGX

Optimize Financial's PTGX Position: Q3 2026 in Review

Optimize Financial opened a new position in Protagonist Therapeutics (PTGX) in Q3 2026: 3,306 shares worth $466K. The stake represents 0.09% of the portfolio and ranks #182 among its holdings.

380 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.

  • Optimize Financial held 3,306 shares of Protagonist Therapeutics worth $466K as of Q3 2026.
  • Protagonist Therapeutics was a new Optimize Financial position in Q3 2026.
  • Protagonist Therapeutics made up 0.09% of Optimize Financial's portfolio in Q3 2026, its #182 holding.
  • 380 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.

Based on Optimize Financial's 13F filing for Q3 2026, filed 12 Nov 2026.